Manufacturers/AbbVie Inc.

AbbVie Inc.

88 drugs in NADAC|1 Generic,87 Brand

View Recalls (10)

AbbVie Inc. lists 88 NDCs in the CMS NADAC file (1 generic, 87 brand), at an average NADAC of $1246.10 per unit, with a week-over-week move of +0.0% across products that moved. The firm's full portfolio, pricing trend, and FDA recalls are listed below.

Total Drugs

88

1G / 87B

Avg Price / Unit

$1246.0980

$1.00 – $22887.44

Avg 7d Change

0.00%

Across 61 drugs with changes

7d Activity

30↑31↓27 flat

of 88 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Keep following this manufacturer

These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.

Frequently Asked Questions

How many drugs does AbbVie Inc. make?

AbbVie Inc. lists 88 NDCs in the CMS NADAC file — 1 generic and 87 brand products.

What is the average price of AbbVie Inc. drugs?

The average NADAC across AbbVie Inc.'s portfolio is $1246.0980 per unit, ranging from $0.9997 to $22887.4386.

What types of drugs does AbbVie Inc. make?

AbbVie Inc. makes drugs across 14 FDA pharmacologic classes. The most common by NDC count are l-Thyroxine (30), Protease Inhibitor (7), Anti-epileptic Agent (6), Mood Stabilizer (6), Cytochrome P450 3A Inhibitor (4).

Has AbbVie Inc. had any drug recalls?

10 FDA recalls are matched to AbbVie Inc. in the openFDA feed, most recently on May 18, 2026.

How has AbbVie Inc.'s pricing changed recently?

Over the past 7 days, 30 AbbVie Inc. products rose and 31 fell, with a portfolio-wide average change of +0.0%.

Drug Portfolio

88 drugs total, 88 shown

Drug ↕Price 7d Change ↕
SKYRIZI 150 MG/ML SYRINGE
risankizumab-rzaa
$22887.4386
per ML
—
SKYRIZI 150 MG/ML PEN
risankizumab-rzaa
$22774.3609
per ML
+0.06%
SKYRIZI 360 MG/2.4 ML ON-BODY
Risankizumab-rzaa
$9572.6650
per ML
+0.07%
HUMIRA(CF) PEN CROHN'S-UC-HS STARTER 80 MG/0.8 ML
Adalimumab
$6745.4280
per EA
—
HUMIRA(CF) PEN 80 MG/0.8 ML
Adalimumab
$6736.7225
per EA
+0.04%
LUPRON DEPOT 22.5 MG 3MO KIT
leuprolide acetate
$6516.2982
per EA
—
LUPRON DEPOT 11.25 MG 3MO KIT
leuprolide acetate
$5437.3967
per EA
+0.12%
HUMIRA(CF) PEN PS-UV-ADOL HS START 80 MG/0.8 ML-40 MG/0.4 ML
Adalimumab
$4441.4694
per EA
—
HUMIRA 40 MG/0.8 ML SYRINGE
Adalimumab
$3369.0926
per EA
-0.07%
HUMIRA(CF) PEN 40 MG/0.4 ML
Adalimumab
$3367.4148
per EA
+0.01%
HUMIRA(CF) 40 MG/0.4 ML SYRINGE
Adalimumab
$3367.1829
per EA
-0.03%
HUMIRA PEN 40 MG/0.8 ML
Adalimumab
$3366.8965
per EA
0.00%
HUMIRA(CF) 20 MG/0.2 ML SYRINGE
Adalimumab
$3366.1230
per EA
—
LUPRON DEPOT 7.5 MG 1 MONTH KT
leuprolide acetate
$2174.1678
per EA
—
LUPRON DEPOT-PED 15 MG KIT
leuprolide acetate
$1875.8391
per EA
—
LUPRON DEPOT 3.75 MG KIT
leuprolide acetate
$1822.0771
per EA
+0.05%
RINVOQ ER 45 MG TABLET
Upadacitinib
$459.6225
per EA
+0.05%
RINVOQ ER 15 MG TABLET
Upadacitinib
$229.3090
per EA
+0.01%
RINVOQ ER 30 MG TABLET
Upadacitinib
$229.2939
per EA
+0.02%
MAVYRET 100-40 MG TABLET
Glecaprevir and Pibrentasvir
$152.9834
per EA
+0.04%
MAVYRET 100-40 MG TABLET
Glecaprevir and Pibrentasvir
$152.9834
per EA
+0.04%
MAVYRET 100-40 MG TABLET
Glecaprevir and Pibrentasvir
$152.9834
per EA
+0.04%
ORILISSA 150 MG TABLET
Elagolix
$43.8087
per EA
-0.02%
QULIPTA 60 MG TABLET
Atogepant
$38.4494
per EA
-0.01%
QULIPTA 30 MG TABLET
Atogepant
$38.3777
per EA
-0.04%
QULIPTA 10 MG TABLET
Atogepant
$38.3583
per EA
-0.18%
VUITY 1.25% EYE DROP
Pilocarpine Hydrochloride
$31.3936
per ML
—
VUITY 1.25% EYE DROP
Pilocarpine Hydrochloride
$23.3947
per ML
—
ORIAHNN 300-1-0.5 MG/300 MG CAPS
Elagolix and Estradiol and Norethisterone
$22.0044
per EA
+0.08%
ORILISSA 200 MG TABLET
Elagolix
$21.9317
per EA
-0.02%
CREON DR 36,000 UNIT CAPSULE
Pancrelipase
$12.6710
per EA
-0.14%
CREON DR 36,000 UNIT CAPSULE
Pancrelipase
$12.6710
per EA
-0.14%
CREON DR 36,000 UNIT CAPSULE
Pancrelipase
$11.9979
per EA
—
NORVIR 100 MG TABLET
Ritonavir
$8.3489
per EA
+0.25%
CREON DR 24,000 UNIT CAPSULE
Pancrelipase
$8.3418
per EA
-0.03%
CREON DR 24,000 UNIT CAPSULE
Pancrelipase
$8.3418
per EA
-0.03%
KALETRA 200-50 MG TABLET
Lopinavir and Ritonavir
$8.3041
per EA
—
KALETRA 200-50 MG TABLET
Lopinavir and Ritonavir
$8.3041
per EA
—
CREON DR 24,000 UNIT CAPSULE
Pancrelipase
$8.1568
per EA
—
DEPAKOTE DR 500 MG TABLET
Divalproex Sodium
$7.4556
per EA
+0.03%
GENGRAF 100 MG CAPSULE
Cyclosporine
$7.4212
per EA
—
DEPAKOTE ER 500 MG TABLET
Divalproex Sodium
$6.4921
per EA
-0.17%
CREON DR 12,000 UNIT CAPSULE
Pancrelipase
$4.2072
per EA
-0.02%
CREON DR 12,000 UNIT CAPSULE
Pancrelipase
$4.2072
per EA
-0.02%
DEPAKOTE DR 250 MG TABLET
Divalproex Sodium
$4.0456
per EA
-0.08%
CREON DR 12,000 UNIT CAPSULE
Pancrelipase
$3.9853
per EA
—
DEPAKOTE ER 250 MG TABLET
Divalproex Sodium
$3.6870
per EA
-0.01%
KALETRA 80 MG-20 MG/ML SOLN
Lopinavir and Ritonavir
$3.1186
per ML
—
GENGRAF 100 MG/ML SOLUTION
Cyclosporine
$2.9312
per ML
—
CREON DR 6,000 UNIT CAPSULE
Pancrelipase
$2.1049
per EA
-0.06%
CREON DR 6,000 UNIT CAPSULE
Pancrelipase
$2.1049
per EA
-0.06%
DEPAKOTE DR 125 MG TABLET
Divalproex Sodium
$2.0552
per EA
+0.14%
CREON DR 6,000 UNIT CAPSULE
Pancrelipase
$1.9927
per EA
—
DEPAKOTE DR 125 MG SPRINKLE CP
Divalproex Sodium
$1.9695
per EA
+0.18%
GENGRAF 25 MG CAPSULE
Cyclosporine
$1.8655
per EA
—
CREON DR 3,000 UNIT CAPSULE
Pancrelipase
$1.7761
per EA
0.00%
CREON DR 3,000 UNIT CAPSULE
Pancrelipase
$1.7761
per EA
0.00%
SYNTHROID 137 MCG TABLET
Levothyroxine Sodium
$1.6631
per EA
-0.04%
SYNTHROID 137 MCG TABLET
Levothyroxine Sodium
$1.6631
per EA
-0.04%
SYNTHROID 125 MCG TABLET
Levothyroxine Sodium
$1.6630
per EA
+0.03%
SYNTHROID 125 MCG TABLET
Levothyroxine Sodium
$1.6630
per EA
+0.03%
SYNTHROID 125 MCG TABLET
Levothyroxine Sodium
$1.6630
per EA
+0.03%
SYNTHROID 88 MCG TABLET
Levothyroxine Sodium
$1.6627
per EA
0.00%
SYNTHROID 88 MCG TABLET
Levothyroxine Sodium
$1.6627
per EA
0.00%
SYNTHROID 75 MCG TABLET
Levothyroxine Sodium
$1.6625
per EA
+0.01%
SYNTHROID 75 MCG TABLET
Levothyroxine Sodium
$1.6625
per EA
+0.01%
SYNTHROID 75 MCG TABLET
Levothyroxine Sodium
$1.6625
per EA
+0.01%
SYNTHROID 50 MCG TABLET
Levothyroxine Sodium
$1.6621
per EA
-0.01%
SYNTHROID 50 MCG TABLET
Levothyroxine Sodium
$1.6621
per EA
-0.01%
SYNTHROID 50 MCG TABLET
Levothyroxine Sodium
$1.6621
per EA
-0.01%
SYNTHROID 100 MCG TABLET
Levothyroxine Sodium
$1.6619
per EA
-0.03%
SYNTHROID 100 MCG TABLET
Levothyroxine Sodium
$1.6619
per EA
-0.03%
SYNTHROID 100 MCG TABLET
Levothyroxine Sodium
$1.6619
per EA
-0.03%
SYNTHROID 150 MCG TABLET
Levothyroxine Sodium
$1.6611
per EA
-0.12%
SYNTHROID 150 MCG TABLET
Levothyroxine Sodium
$1.6611
per EA
-0.12%
SYNTHROID 150 MCG TABLET
Levothyroxine Sodium
$1.6611
per EA
-0.12%
SYNTHROID 112 MCG TABLET
Levothyroxine Sodium
$1.6600
per EA
0.00%
SYNTHROID 112 MCG TABLET
Levothyroxine Sodium
$1.6600
per EA
0.00%
SYNTHROID 25 MCG TABLET
Levothyroxine Sodium
$1.6595
per EA
+0.01%
SYNTHROID 25 MCG TABLET
Levothyroxine Sodium
$1.6595
per EA
+0.01%
SYNTHROID 175 MCG TABLET
Levothyroxine Sodium
$1.6588
per EA
-0.02%
SYNTHROID 175 MCG TABLET
Levothyroxine Sodium
$1.6588
per EA
-0.02%
SYNTHROID 200 MCG TABLET
Levothyroxine Sodium
$1.6579
per EA
+0.01%
SYNTHROID 200 MCG TABLET
Levothyroxine Sodium
$1.6579
per EA
+0.01%
SYNTHROID 200 MCG TABLET
Levothyroxine Sodium
$1.6579
per EA
+0.01%
SYNTHROID 300 MCG TABLET
Levothyroxine Sodium
$1.6566
per EA
+0.02%
SYNTHROID 300 MCG TABLET
Levothyroxine Sodium
$1.6566
per EA
+0.02%
TRICOR 145 MG TABLET
Fenofibrate
$0.9997
per EA
—

FDA Recalls (10)

Recalls matched by company name. Verify current status with FDA.

D-0551-2026 →
Ongoing
Class III

PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie company, North Chicago, IL 60064, Product of France, NDC 11980-174-10.

Failed Stability Specifications

Initiated: 5/18/2026
D-0665-2024 →
Ongoing
Class II

Refresh LACRI-LUBE, (42.5% Mineral Oil, 57.3% White Petrolatum) Lubricant Eye Ointment, Net wt, 0.12 oz (3.5g) Tube, Distributed by: Allergen, an AbbVie company, Madison, NJ 07940, UPC code: 300230312042

Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.

Initiated: 9/16/2024
D-0664-2024 →
Ongoing
Class II

Refresh P.M., (Mineral Oil 42.5%, White Petrolatum 57.3%) Lubricant Eye Ointment, Net wt, 0.12 oz (3.5g) Tube, Distributed by: Allergen, an AbbVie company, Madison, NJ 07940, UPC code: 300230667043,

Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.

Initiated: 9/16/2024
D-0088-2024 →
Ongoing
Class III

Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. North Chicago, IL 60064, U.S.A. NDC 0074-7068-11

Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.

Initiated: 10/17/2023
D-0412-2018 →
Terminated
Class III

Ultane (sevoflurane), 250 mL, Inhalation Anesthetic, Rx only, Manufactured by: AbbVie Inc., North Chicago, IL 60064, USA. NDC 0074-4456-51

Defective container: presence of a hole in the liners of the caps covering the product bottle, introducing possibility of leakage.

Initiated: 1/22/2018
D-0033-2018 →
Terminated
Class III

AndroGel (testosterone gel) 1.62%, 88 gm metered-dose pump, 20.25 mg of testosterone per pump actuation, 60 metered pump actuations, Rx Only, Marketed by: AbbVie Inc., North Chicago, IL 60064 USA. NDC: 0051-8462-33

Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.

Initiated: 9/8/2017
D-0034-2018 →
Terminated
Class III

AndroGel (testosterone gel) 1.62%, 40.5mg in 2.5g aluminum foil packet, 30 Packets per carton. Rx Only. Marketed by: AbbVie Inc., North Chicago, IL 60064 USA. NDC: 0051-8462-30

Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.

Initiated: 9/8/2017
D-0495-2017 →
Terminated
Class II

Duopa (carbidopa and levodopa enteral suspension), 4.63 mg/20 mg per mL, 100 mL cassette, 7 cassettes per carton, Rx Only, AbbVie Inc., North Chicago, IL 60064 --- NDC 0074-3012-07

Failed Stability Specifications: confirmed out of specification results obtained during refrigerated material stability testing indicating that drug may settle within drug cassettes nearing the end of their refrigerated shelf-life

Initiated: 1/13/2017
D-0833-2016 →
Terminated
Class III

Zemplar (paricalcitol) capsules, 1 mcg, 30-count bottle, Rx Only, Mfd for AbbVie Inc. North Chicago, IL 60064, NDC 0074-4317-30.

Failed Content Uniformity Specifications

Initiated: 3/24/2016
D-901-2013 →
Terminated
Class III

Mavik¿ trandolapril tablets 4mg, 100 count bottle, Rx only, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ for Abbott Laboratories, North Chicago, IL 60064, USA

Labeling: Incorrect Package Insert; product packaged with outdated version of the insert

Initiated: 8/1/2013